Association of Early Caffeine Therapy with Risk Reduction of Moderate-to-Severe Bronchopulmonary Dysplasia in Preterm Infants
Open Access
- 1 January 2025
- journal article
- Published by XMLink in Perinatology
- Vol. 36 (2) , 43-51
Abstract
Lee EJ, et al. Perinatology. 2025 Jun;36(2):43-51. https://doi.org/10.14734/PN.2025.36.2.43Keywords
This publication has 35 references indexed in Scilit:
- The South Korean health-care system in crisisThe Lancet, 2024
- International Classification of Retinopathy of Prematurity, Third EditionOphthalmology, 2021
- Caffeine: Well-known as psychotropic substance, but little as immunomodulatorImmunobiology, 2018
- Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and TreatmentLung, 2018
- Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiologyRespiratory Medicine, 2017
- Trends in Caffeine Use and Association between Clinical Outcomes and Timing of Therapy in Very Low Birth Weight InfantsThe Journal of Pediatrics, 2014
- Functional echocardiography in staging for ductal disease severityEuropean Journal of Pediatrics, 2012
- Correlation between Serum Caffeine Levels and Changes in Cytokine Profile in a Cohort of Preterm InfantsThe Journal of Pediatrics, 2011
- Apnoea of prematurityPaediatric Respiratory Reviews, 2004
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978